Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer

Published:2011-09 Issue:5 Volume:12 Page:407-420
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Aljuffali Ibrahim A.,Mock Jason N.,Costyn Leah J.,Nguyen Ha,Nagy Tamas,Cummings Brian S.,Arnold Robert D.

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.12.5.15950

Reference51 articles.

1. Novel Clinical Trials in Androgen-Independent Prostate Cancer

2. Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update

3. Management Strategies for Locally Advanced Prostate Cancer

4. The development of androgen-independent prostate cancer

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial–mesenchymal Transition in Aggressive Variant Prostate Cancers;Cancer Research Communications;2023-07-19

2. Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial–Mesenchymal Transition;International Journal of Molecular Sciences;2023-05-09

3. Co-axial electrospraying of injectable multi-cancer drugs nanocapsules with polymer shells for targeting aggressive breast cancers;Cancer Nanotechnology;2022-02-22

4. The Andrographolide analogue 3A.1 synergizes with Taxane derivatives in aggressive metastatic prostate cancers by upregulation of Heat Shock proteins and downregulation of MAT2A-mediated cell migration and invasion;Journal of Pharmacology and Experimental Therapeutics;2021-12-23

5. Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer;Frontiers in Pharmacology;2021-12-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3